Potassium Ion

Potassium Ion

SCHEMBL725645

CCCCCCCCCCCCC(CO)OS(=O)(=O)[O-].[K+]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
MAPK1 P28482 2/20 0.42
MAPT P10636 2/20 0.42
RECQL P46063 2/20 0.42
BLM P54132 2/20 0.42
GLA P06280 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
EPHX2 P34913 1/20 0.42
MGAM O43451 3/20 0.41
PRKCA P17252 3/20 0.41
PRKCE Q02156 1/20 0.41
PRKCQ Q04759 1/20 0.41
PRKCD Q05655 1/20 0.41
TP53 P04637 2/20 0.38
CYP2D6 P10635 2/20 0.37
SPHK1 Q9NYA1 1/20 0.37
GMNN O75496 1/20 0.37
POLB P06746 1/20 0.37
THPO P40225 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL725596 0.97 RECQL (0.46) LMNAMAPK1MAPTRECQLBLM
Potassium Ion SCHEMBL29176441 0.91 RECQL (0.48) MAPK1RECQLBLMGLAHPGD
SCHEMBL17336087 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD
SCHEMBL4641831 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD
SCHEMBL5154873 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD
SCHEMBL10496151 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD
SCHEMBL10439386 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD
SCHEMBL5157776 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD
SCHEMBL17336063 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD
SCHEMBL15797034 0.89 RECQL (0.52) MAPK1RECQLBLMGLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2575807-B1 FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME NOVAK MAJA (HR) 2014-02-19 EP claimed
EP-2575807-A1 FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME Novak, Maja (HR) 2013-04-10 EP claimed
WO-2011148203-A1 FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME NOVAK MAJA (HR) 2011-12-01 WO claimed
WO-2010097643-A1 FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE NOVATECH ISTRAZIVANJE D.O.O. (HR) 2010-09-02 WO claimed
WO-2010018418-A1 FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON NOVATECH D.O.O. (HR) 2010-02-18 WO claimed
WO-2009133413-A1 FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS A THERAPEUTIC AGENT FOR REMOVAL OF TOXINS, BACTERIA AND VIRUSES FROM ORGANISM NOVATECH D.O.O. (HR) 2009-11-05 WO claimed
EP-2575807-B1 FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME NOVAK MAJA (HR) 2014-02-19 EP disclosed
EP-2575807-A1 FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME Novak, Maja (HR) 2013-04-10 EP disclosed
WO-2011148203-A1 FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME NOVAK MAJA (HR) 2011-12-01 WO disclosed
WO-2010097643-A1 FORMULATION BASED ON MICRONIZED ZEOLITE, GREEN TEA EXTRACT, AND GENISTEIN AS A THERAPEUTIC AGENT FOR REDUCTION OF BODY WEIGHT AND CELLULITE NOVATECH ISTRAZIVANJE D.O.O. (HR) 2010-09-02 WO disclosed
WO-2010018418-A1 FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS THERAPEUTIC AGENT PROVIDING HIGHLY BIOAVAILABLE SILICON NOVATECH D.O.O. (HR) 2010-02-18 WO disclosed
WO-2009133413-A1 FORMULATION BASED ON MICRONIZED CLINOPTILOLITE AS A THERAPEUTIC AGENT FOR REMOVAL OF TOXINS, BACTERIA AND VIRUSES FROM ORGANISM NOVATECH D.O.O. (HR) 2009-11-05 WO disclosed